Clinical Trials Logo

Filter by:
NCT ID: NCT05424679 Completed - Anxiety Clinical Trials

Piloting +Connection is Medicine / The Healing Spirits Program

Start date: August 24, 2022
Phase: N/A
Study type: Interventional

This study aims to assess what benefit, if any, an individualized coping plan and facilitating connections to care through referral coordination in conjunction with culturally tailored caring messages, (herein called the +Connection is Medicine intervention (Navajo Nation study name; +CiM)/The Healing Spirits Program (White Mountain Apache Tribe Study Name; HSP) have on the mental health of American Indian (AI) youth and caregivers who were previously identified as having high levels of anxiety and depression as part of their participation in a cohort study called Project SafeSchools (NIH Grant No.: OT2HD107543).

NCT ID: NCT05424523 Completed - Allergic Asthma Clinical Trials

Effectiveness and Safety of Omalizumab in Children With Allergic Asthma.

Start date: February 25, 2021
Phase:
Study type: Observational

The study was the non-interventional, retrospective study aimed to assess the effectiveness and safety of omalizumab in children with allergic asthma in China, and described patient profiles and treatment patterns of omalizumab in real-world practice.

NCT ID: NCT05424471 Completed - Obesity Clinical Trials

Preventing Early Childhood Obesity, Part 1: Long-term Follow-up

PECO1-LTF
Start date: May 1, 2021
Phase: N/A
Study type: Interventional

This study extends follow up on of Native American (NA) mothers and their children (now age 3-5 years) enrolled in the 1:1 randomized controlled trial of the Family Spirit Nurture (FSN) intervention designed to prevent early childhood obesity (PECO 1). The investigators will examine whether positive FSN impacts on sugar sweetened beverage (SSB) consumption and healthy growth in the first year of life were sustained. The investigators will also examine the effects of the emergency COVID-19 water solutions on water insecurity, early childhood SSB consumption, and growth, and explore how COVID-19 affected child feeding patterns and weight status either through changes in maternal mental health or household food access.

NCT ID: NCT05424146 Completed - Clinical trials for Post Traumatic Stress Disorder

Efficacy of Evidence-Based PTSD Treatment Via Prebiotic Supplementation

Start date: June 6, 2022
Phase: N/A
Study type: Interventional

Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder, which results from exposure to traumatic events. Veterans are more than twice as likely to suffer from PTSD compared to civilians. Current interventions for the treatment of PTSD are evidence-based psychotherapies, such as Cognitive Processing Therapy (CPT). Therefore, we plan to compare Cognitive Processing Therapy (CPT) with and without a novel prebiotic bar designed to beneficially modulate the microbiota to determine the utility of this combined approach to positively impact PTSD symptoms. We will conduct a 12-week randomized, double-blind, placebo-controlled, cross-sectional trial in veterans with PTSD. Participants will be randomized to receive CPT + prebiotic or CPT + placebo. They will be provided a supply of prebiotic or non prebiotic bars for 12 weeks. At three different time points, participants will complete questionnaires and complete questionnaires and produce a stool sample ( weeks 1,2, and 12). All participants will be recruited from the two-week in-person Intensive Outpatient Program (IOP) at the Rush Road Home Program, where they will be receiving CPT.

NCT ID: NCT05424120 Completed - Pleural Effusion Clinical Trials

Thoracentesis QI Study

Start date: January 18, 2022
Phase: N/A
Study type: Interventional

Researchers will compare 3 standard of care methods of pleural fluid drainage during therapeutic thoracentesis. Patients are randomized to manual aspiration, vacuum bottle drainage or wall suction methods. Primary outcome is procedural time with secondary outcomes of pain and dyspnea scores.

NCT ID: NCT05423873 Completed - Wrinkle Clinical Trials

A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging

Start date: March 17, 2021
Phase: N/A
Study type: Interventional

This open-label, multi-center clinical trial was conducted to evaluate the dual skincare regimen of vitamin C serum and moisturizing sunscreen SPF 45 to improve facial hyperpigmentation and photodamage after 12 weeks of twice daily use in healthy female subjects between 35 - 60 years old. A total of 33 subjects completed study participation.

NCT ID: NCT05423730 Completed - Breast Cancer Clinical Trials

Alcohol and Breast Cancer (ABC) Trial

Start date: September 1, 2022
Phase: Early Phase 1
Study type: Interventional

This research study is a pilot study, which is the first time investigators are examining the effect of light alcohol consumption on sex hormones among postmenopausal women with estrogen receptor-positive (ER+) breast cancer taking an aromatase inhibitor The names of the study exposures involved in this study are: - White wine - White grape juice

NCT ID: NCT05423509 Completed - Clinical trials for Scoliosis Idiopathic Adolescent Treatment

Myofascial and Articular Treatment of Adolescent Idiopathic Scoliosis

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Randomized controlled trial of participants with scoliosis into standard treatment with observation/bracing and the other group will have the added treatment of dynamic myofascial manipulation for 6 months.

NCT ID: NCT05423470 Completed - Clinical trials for Intermittent Hypoxia

Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals

Start date: May 30, 2019
Phase: N/A
Study type: Interventional

The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that intermittent hypoxia will attenuate the reduction in flow-mediated dilation following ischemia-reperfusion injury.

NCT ID: NCT05423431 Completed - Prostate Cancer Clinical Trials

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Start date: November 9, 2020
Phase:
Study type: Observational

Dosimetry efficacy of the hydrogel spacer.